LoginRegister
    USFDA alerts iconic Johnsons Baby Powder contaminated with AsbestosUSFDA alerts iconic Johnsons Baby Powder contaminated with Asbestos
    Lupin largest, most advanced oral solid dosage facility gets EIR from USFDALupin largest, most advanced oral solid dosage facility gets EIR from USFDA
    Indoco Remedies successfully clears USFDA inspection of CRO facility AnaCipherIndoco Remedies successfully clears USFDA inspection of CRO facility AnaCipher
    Merck gets European nod for Ebola vaccine ErveboMerck gets European nod for Ebola vaccine Ervebo
    Eli Lilly pancreatic cancer drug Pegilodecakin fails to meet endpointEli Lilly pancreatic cancer drug Pegilodecakin fails to meet endpoint
    Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in IndiaCipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in...
    Glenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mgGlenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg
    USFDA red flag to Torrent Pharmas Indrad facilityUSFDA red flag to Torrent Pharma's Indrad facility
    Roche bags FDA approval of Xofluza (baloxavir marboxil) for treatment of acute, uncomplicated influenzaRoche bags FDA approval of Xofluza (baloxavir marboxil) for treatment of acute, uncomplicated...
    Tevas UK arm recalls some batches of Ranitidine: Medicines watchdogTeva's UK arm recalls some batches of Ranitidine: Medicines watchdog
    USFDA red flags Glenmark over batch failure investigations at Baddi facilityUSFDA red flags Glenmark over batch failure investigations at Baddi facility
    Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficultiesSun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in...
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X